Early recycling compartment trafficking of CD1a is essential for its intersection and presentation of lipid antigens.
A major step in understanding differences in the nature of Ag presentation was the realization that MHC class I samples peptides transported to the endoplasmic reticulum from the cytosol, whereas MHC class II samples peptides from lysosomes. In contrast to MHC class I and II molecules that present protein Ags, CD1 molecules present lipid Ags for recognition by specific T cells. Each of the five members of the CD1 family (CD1a-e) localizes to a distinct subcompartment of endosomes. Accordingly, it has been widely assumed that the distinct trafficking of CD1 isoforms must also have evolved to enable them to sample lipid Ags that traffic via different routes. Among the CD1 isoforms, CD1a is unusual because it does not have a tyrosine-based cytoplasmic sorting motif and uniquely localizes to the early endocytic recycling compartment. This led us to predict that CD1a might have evolved to focus on lipids that localize to early endocytic/recycling compartments. Strikingly, we found that the glycolipid Ag sulfatide also localized almost exclusively to early endocytic and recycling compartments. Consistent with colocalization of CD1a and sulfatide, wild-type CD1a molecules efficiently presented sulfatide to CD1a-restricted, sulfatide-specific T cells. In contrast, CD1a:CD1b tail chimeras, that retain the same Ag-binding capacity as CD1a but traffic based on the cytoplasmic tail of CD1b to lysosomes, failed to present sulfatide efficiently. Thus, the intracellular trafficking route of CD1a is essential for efficient presentation of lipid Ags that traffic through the early endocytic and recycling pathways.
Cernadas
Manuela
M
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Cavallari
Marco
M
Watts
Gerald
G
Mori
Lucia
L
De Libero
Gennaro
G
Brenner
Michael B
MB
D000818:Animals; D017951:Antigen Presentation / Q000276:immunology*; D018949:Antigens, CD1 / Q000235:genetics / Q000378:metabolism*; D002417:Cattle; D002465:Cell Movement / Q000235:genetics / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism; D004705:Endocytosis / Q000235:genetics / Q000276:immunology; D006367:HeLa Cells; D006801:Humans; D008070:Lipopolysaccharides / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D008247:Lysosomes / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D050506:Mutant Chimeric Proteins / Q000276:immunology / Q000378:metabolism; D011485:Protein Binding / Q000235:genetics / Q000276:immunology; D015398:Signal Transduction / Q000235:genetics / Q000276:immunology; D013433:Sulfoglycosphingolipids / Q000276:immunology* / Q000378:metabolism
D018949:Antigens, CD1; C419393:CD1a antigen; C419394:CD1b antigen; D008070:Lipopolysaccharides; D050506:Mutant Chimeric Proteins; D013433:Sulfoglycosphingolipids; C050016:lipoarabinomannan